发明名称 |
Perfusion solution |
摘要 |
The invention provides a perfusion stock composition, for preserving a donor organ for transplantation, comprising: a source of 60 to 100 mM Na+; a source of 10 to 20 mM K+; a source of 5 to 10 mM Mg2+; a source of 0.25 to 0.75 mM Ca2+; 10 to 40 mM Tris(hydroxymethyl)aminomethane hydrochloride (Tris or THAM), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 3-(N-morpholino)propanesulfonic acid (MOPS), 2-(N-morpholino)ethanesulfonic acid (MES), N,/N-bis-(2-hydroxyethyl)-2-aminoethansulfonic acid (BES), or N/-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES); a source of 10 to 30 mM HC03−; 1 to 30 mM glucose; 1 to 20 U/L insulin; 1 to 10 mM fructose diphosphate or a salt thereof; 1 to 40 mM aspartate or glutamate; 1 to 10 mM adenosine, cAMP or cGMP; 1 to 10 mM reduced glutathione; and 30 to 100 mM lactobionate or mannitol; and optionally a diluent. The invention also provides a perfusion composition, a kit, a method, and a perfusion apparatus, each related to the perfusion stock composition. |
申请公布号 |
US9060507(B2) |
申请公布日期 |
2015.06.23 |
申请号 |
US201113818670 |
申请日期 |
2011.09.01 |
申请人 |
Perfusion Fluid Technologies Inc |
发明人 |
Alford Marlin;Dowben Robert;Rosenfeldt Franklin |
分类号 |
A01N1/02 |
主分类号 |
A01N1/02 |
代理机构 |
Law Offices of Ken Dallara |
代理人 |
Law Offices of Ken Dallara ;Dallara Ken |
主权项 |
1. A sterile aqueous solution for gravity microperfusion of donor hearts, the solution consisting of:
(a) between 10 and 20 mM potassium chloride; (b) between 5 and 10 mM magnesium; (c) between 0.2 and 1.0 mM calcium; (d) between 10 and 40 mM Tris(hydroxymethyl)aminomethane hydrochloride (Tris or THAM), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HE PES), 3-(Nmorpholino)propanesulfonic acid (MOPS), 2-(N-morpholino)ethanesulfonic acid (MES), N,N-bis-(2-hydroxyethyl)-2-aminoethansulfonic acid (BES), or Ntris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES); (e) between 10 and 30 mM sodium bicarbonate, for enhancing the out-flow of CO2 from cells; (f) between 1 and 40 mM aspartate; (g) between 1 and 30 mM glucose; (h) between 1 and 20 mM adenosine, cAMP or cGMP; (i) between 30 and 100 mM lactobionate; (j) between 1 and 20 units/L insulin; (k) between 1 and 10 mM fructose diphosphate or a salt thereof; (l) between 1 and 10 mM reduced glutathione; (m) oxygen saturation using 100% 02; and (n) a sufficient concentration of sodium to maintain an ionic strength of sodium in said sterile aqueous solution is to be between 110 and 120 mM. |
地址 |
Redlands CA US |